COLLINS Asha 4
4 · IDEXX LABORATORIES INC /DE · Filed Dec 3, 2020
Insider Transaction Report
Form 4
COLLINS Asha
Director
Transactions
- Award
Deferred Stock Unit
2020-12-01+109→ 109 total→ Common Stock (109 underlying) - Award
Non-Qualified Stock Option (right-to-buy)
2020-12-01+358→ 358 totalExercise: $467.86Exp: 2030-11-30→ Common Stock (358 underlying)
Footnotes (4)
- [F1]This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from her election to the IDEXX Laboratories, Inc. Board of Directors on November 11, 2020 until the 2021 annual meeting of stockholders.
- [F2]Each deferred stock unit ('DSU') represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These DSUs will fully vest on the date of the 2021 annual meeting of stockholders or May 6, 2021, whichever event occurs earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.
- [F3]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 6, 2021.
- [F4]Not applicable.